Get the Stockscreener App
0.1834
4.32%
0.0076
After Hours:
.19
0.0066
+3.60%
Aclarion Inc stock is traded at $0.1834, with a volume of 302.86K.
It is up +4.32% in the last 24 hours and down -12.42% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$0.1758
Open:
$0.19
24h Volume:
302.86K
Relative Volume:
0.64
Market Cap:
$1.73M
Revenue:
$75,400
Net Income/Loss:
$-4.91M
P/E Ratio:
-0.3275
EPS:
-0.56
Net Cash Flow:
$-3.77M
1W Performance:
+4.15%
1M Performance:
-12.42%
6M Performance:
-44.34%
1Y Performance:
-96.48%
1-Day Range:
$0.18
$0.19
1-Week Range:
$0.173
$0.19
52-Week Range:
$0.1599
$9.9008
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Aclarion Inc Stock (ACON) Latest News
Aclarion study links back pain to MRI-detected changes By Investing.com - Investing.com South Africa
Aclarion (NASDAQ:ACON) Stock Quotes, Forecast and News Summary - Benzinga
Aclarion's Nociscan AI Advances Understanding of Modic Changes in Chronic Low Back Pain - Vancity Buzz
Aclarion study links back pain to MRI-detected changes - Investing.com India
Aclarion study links back pain to MRI-detected changes - Investing.com
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes - The Manila Times
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes - StockTitan
Aptevo Therapeutics Inc. (NASDAQ:APVO) to Post Q3 2024 Earnings of ($0.57) Per Share, Roth Capital Forecasts - Defense World
Benjamin F. Edwards & Company Inc. Raises Stock Holdings in T. Rowe Price U.S. Equity Research ETF (NYSEARCA:TSPA) - Defense World
Benjamin F. Edwards & Company Inc. Sells 8,320 Shares of iShares ESG Aware MSCI USA ETF (NASDAQ:ESGU) - Defense World
Aclarion, Inc. initiates $10 million at-the-market offering - Investing.com India
Aclarion, Inc. initiates $10 million at-the-market offering By Investing.com - Investing.com Canada
Aclarion, Inc. initiates $10 million at-the-market offering - Investing.com
Aclarion shareholders approve reverse stock split proposal By Investing.com - Investing.com Canada
Aclarion shareholders approve reverse stock split proposal - Investing.com
Aclarion shareholders approve reverse stock split proposal By Investing.com - Investing.com Australia
Mitsubishi UFJ Adjusts Stake in Australian Clinical Labs - TipRanks
Australian Clinical Labs Substantial Holder Update - TipRanks
ACLX, HROW Deliver Triple-Digit ReturnsDid You Cash In? - Nasdaq
Accenture (ACN) Set to Announce Quarterly Earnings on Thursday - Defense World
Alignment Healthcare (NASDAQ:ALHC) Sees Strong Trading Volume - Defense World
Short Interest in Casey’s General Stores, Inc. (NASDAQ:CASY) Increases By 6.3% - Defense World
Alcidion Reports Lapse of Performance Rights - TipRanks
ACV auctions CFO William Zerella sells over $1.6 million in company stock - Investing.com Canada
AstraZeneca PLC ADR outperforms market on strong trading day - MarketWatch
Accenture (NYSE:ACN) PT Raised to $365.00 - Defense World
Arcellx Sees Unusually Large Options Volume (NASDAQ:ACLX) - Defense World
Smart Investors Are Holding Acadia Healthcare Stock Now: Here's Why - Barchart
AGC Biologics lays off 85 from Longmont, Boulder sites - BizWest
Research Analysts’ Price Target Changes for September 18th (ACN, AGF.B, ANIP, ANP, APA, AZPN, BDC, BKR, BLDR, BNTX) - Defense World
Investors in Acadia Healthcare Company (NASDAQ:ACHC) have seen impressive returns of 143% over the past five years - Yahoo Finance
Accolade president Cavanaugh sells shares worth $643 - Investing.com
Accolade CFO sells over $500 worth of shares to cover tax obligations - Investing.com
Breaking Down Acrivon: Deep Dive Into Revenue, Profitability, And Prospects (NASDAQ:ACRV) - Seeking Alpha
Metric Deep Dive: Understanding Accenture plc (ACN) Through its Ratios - The Dwinnex
Accenture PLC (ACN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
A History of Outperforming Analyst Forecasts and Beating the Odds: Astera Labs Inc. (ALAB) - SETE News
Is it possible to buy Axcelis Technologies Inc(ACLS) shares at a good price now? - US Post News
Stock Surge: Accuray Inc (ARAY) Closes at 1.90, Marking a -12.84 Increase/Decrease - The Dwinnex
American Century Companies Inc. Boosts Stock Position in Accel Entertainment, Inc. (NYSE:ACEL) - Defense World
Aclaris doses first subject in Phase IIa atopic dermatitis treatment trial - Clinical Trials Arena
How the (CCAP) price action is used to our Advantage - Stock Traders Daily
American Century Companies Inc. Purchases 19,411 Shares of Arch Capital Group Ltd. (NASDAQ:ACGL) - Defense World
Astralis has brought on cadiaN as its new in-game leader - Gamereactor UK
Capricor Therapeutics (NASDAQ:CAPR) Receives “Buy” Rating from HC Wainwright - Defense World
Aclaris Therapeutics (NASDAQ:ACRS) Receives “Neutral” Rating from HC Wainwright - Defense World
(CACC) Investment Analysis - Stock Traders Daily
UBS Group Ends Substantial Stake in Australian Clinical Labs - TipRanks
Legal & General sells Aberdeen housebuilder Cala to private equity groups - Aberdeen Live
Australian Clinical Labs Shareholder Stake Shifts - TipRanks
AstraZeneca PLC (NASDAQ:AZN) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.31%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):